line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,THYROCARE.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.376031,THYROCARE.NS
Normalized EBITDA,2025-03-31 00:00:00,2037500000.0,THYROCARE.NS
Total Unusual Items,2025-03-31 00:00:00,0.0,THYROCARE.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,0.0,THYROCARE.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,915100000.0,THYROCARE.NS
Reconciled Depreciation,2025-03-31 00:00:00,552600000.0,THYROCARE.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,1910800000.0,THYROCARE.NS
EBITDA,2025-03-31 00:00:00,2037500000.0,THYROCARE.NS
EBIT,2025-03-31 00:00:00,1484900000.0,THYROCARE.NS
Net Interest Income,2025-03-31 00:00:00,-30500000.0,THYROCARE.NS
Interest Expense,2025-03-31 00:00:00,30500000.0,THYROCARE.NS
Interest Income,2025-03-31 00:00:00,,THYROCARE.NS
Normalized Income,2025-03-31 00:00:00,915100000.0,THYROCARE.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,915100000.0,THYROCARE.NS
Total Expenses,2025-03-31 00:00:00,5522500000.0,THYROCARE.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,THYROCARE.NS
Diluted Average Shares,2025-03-31 00:00:00,53577283.0,THYROCARE.NS
Basic Average Shares,2025-03-31 00:00:00,53420899.0,THYROCARE.NS
Diluted EPS,2025-03-31 00:00:00,17.08,THYROCARE.NS
Basic EPS,2025-03-31 00:00:00,17.13,THYROCARE.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,915100000.0,THYROCARE.NS
Net Income Common Stockholders,2025-03-31 00:00:00,915100000.0,THYROCARE.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,THYROCARE.NS
Net Income,2025-03-31 00:00:00,915100000.0,THYROCARE.NS
Minority Interests,2025-03-31 00:00:00,7600000.0,THYROCARE.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,907500000.0,THYROCARE.NS
Net Income Continuous Operations,2025-03-31 00:00:00,907500000.0,THYROCARE.NS
Tax Provision,2025-03-31 00:00:00,546900000.0,THYROCARE.NS
Pretax Income,2025-03-31 00:00:00,1454400000.0,THYROCARE.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,148300000.0,THYROCARE.NS
Special Income Charges,2025-03-31 00:00:00,0.0,THYROCARE.NS
Other Special Charges,2025-03-31 00:00:00,,THYROCARE.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-30500000.0,THYROCARE.NS
Total Other Finance Cost,2025-03-31 00:00:00,,THYROCARE.NS
Interest Expense Non Operating,2025-03-31 00:00:00,30500000.0,THYROCARE.NS
Interest Income Non Operating,2025-03-31 00:00:00,,THYROCARE.NS
Operating Income,2025-03-31 00:00:00,1351000000.0,THYROCARE.NS
Operating Expense,2025-03-31 00:00:00,3611700000.0,THYROCARE.NS
Other Operating Expenses,2025-03-31 00:00:00,1791400000.0,THYROCARE.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,552600000.0,THYROCARE.NS
Depreciation Income Statement,2025-03-31 00:00:00,552600000.0,THYROCARE.NS
Selling General And Administration,2025-03-31 00:00:00,,THYROCARE.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,THYROCARE.NS
General And Administrative Expense,2025-03-31 00:00:00,,THYROCARE.NS
Rent And Landing Fees,2025-03-31 00:00:00,,THYROCARE.NS
Gross Profit,2025-03-31 00:00:00,4962700000.0,THYROCARE.NS
Cost Of Revenue,2025-03-31 00:00:00,1910800000.0,THYROCARE.NS
Total Revenue,2025-03-31 00:00:00,6873500000.0,THYROCARE.NS
Operating Revenue,2025-03-31 00:00:00,6873500000.0,THYROCARE.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,THYROCARE.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.275995,THYROCARE.NS
Normalized EBITDA,2024-03-31 00:00:00,1471900000.0,THYROCARE.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,THYROCARE.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,THYROCARE.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,707600000.0,THYROCARE.NS
Reconciled Depreciation,2024-03-31 00:00:00,470100000.0,THYROCARE.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,1667000000.0,THYROCARE.NS
EBITDA,2024-03-31 00:00:00,1471900000.0,THYROCARE.NS
EBIT,2024-03-31 00:00:00,1001800000.0,THYROCARE.NS
Net Interest Income,2024-03-31 00:00:00,-42000000.0,THYROCARE.NS
Interest Expense,2024-03-31 00:00:00,42000000.0,THYROCARE.NS
Interest Income,2024-03-31 00:00:00,27100000.0,THYROCARE.NS
Normalized Income,2024-03-31 00:00:00,707600000.0,THYROCARE.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,707600000.0,THYROCARE.NS
Total Expenses,2024-03-31 00:00:00,4814600000.0,THYROCARE.NS
Rent Expense Supplemental,2024-03-31 00:00:00,41500000.0,THYROCARE.NS
Diluted Average Shares,2024-03-31 00:00:00,52727273.0,THYROCARE.NS
Basic Average Shares,2024-03-31 00:00:00,52727273.0,THYROCARE.NS
Diluted EPS,2024-03-31 00:00:00,13.42,THYROCARE.NS
Basic EPS,2024-03-31 00:00:00,13.42,THYROCARE.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,707600000.0,THYROCARE.NS
Net Income Common Stockholders,2024-03-31 00:00:00,707600000.0,THYROCARE.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,THYROCARE.NS
Net Income,2024-03-31 00:00:00,707600000.0,THYROCARE.NS
Minority Interests,2024-03-31 00:00:00,12700000.0,THYROCARE.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,694900000.0,THYROCARE.NS
Net Income Continuous Operations,2024-03-31 00:00:00,694900000.0,THYROCARE.NS
Tax Provision,2024-03-31 00:00:00,264900000.0,THYROCARE.NS
Pretax Income,2024-03-31 00:00:00,959800000.0,THYROCARE.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,93700000.0,THYROCARE.NS
Special Income Charges,2024-03-31 00:00:00,0.0,THYROCARE.NS
Other Special Charges,2024-03-31 00:00:00,9300000.0,THYROCARE.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-42000000.0,THYROCARE.NS
Total Other Finance Cost,2024-03-31 00:00:00,13300000.0,THYROCARE.NS
Interest Expense Non Operating,2024-03-31 00:00:00,42000000.0,THYROCARE.NS
Interest Income Non Operating,2024-03-31 00:00:00,27100000.0,THYROCARE.NS
Operating Income,2024-03-31 00:00:00,904200000.0,THYROCARE.NS
Operating Expense,2024-03-31 00:00:00,3147600000.0,THYROCARE.NS
Other Operating Expenses,2024-03-31 00:00:00,1598900000.0,THYROCARE.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,470100000.0,THYROCARE.NS
Depreciation Income Statement,2024-03-31 00:00:00,470100000.0,THYROCARE.NS
Selling General And Administration,2024-03-31 00:00:00,656700000.0,THYROCARE.NS
Selling And Marketing Expense,2024-03-31 00:00:00,326600000.0,THYROCARE.NS
General And Administrative Expense,2024-03-31 00:00:00,330100000.0,THYROCARE.NS
Rent And Landing Fees,2024-03-31 00:00:00,41500000.0,THYROCARE.NS
Gross Profit,2024-03-31 00:00:00,4051800000.0,THYROCARE.NS
Cost Of Revenue,2024-03-31 00:00:00,1667000000.0,THYROCARE.NS
Total Revenue,2024-03-31 00:00:00,5718800000.0,THYROCARE.NS
Operating Revenue,2024-03-31 00:00:00,5718800000.0,THYROCARE.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,15863415.73541,THYROCARE.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.273507,THYROCARE.NS
Normalized EBITDA,2023-03-31 00:00:00,1238500000.0,THYROCARE.NS
Total Unusual Items,2023-03-31 00:00:00,58000000.0,THYROCARE.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,58000000.0,THYROCARE.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,644900000.0,THYROCARE.NS
Reconciled Depreciation,2023-03-31 00:00:00,387100000.0,THYROCARE.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,1632300000.0,THYROCARE.NS
EBITDA,2023-03-31 00:00:00,1296500000.0,THYROCARE.NS
EBIT,2023-03-31 00:00:00,909400000.0,THYROCARE.NS
Net Interest Income,2023-03-31 00:00:00,-34500000.0,THYROCARE.NS
Interest Expense,2023-03-31 00:00:00,23500000.0,THYROCARE.NS
Interest Income,2023-03-31 00:00:00,13800000.0,THYROCARE.NS
Normalized Income,2023-03-31 00:00:00,602763415.73541,THYROCARE.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,644900000.0,THYROCARE.NS
Total Expenses,2023-03-31 00:00:00,4420500000.0,THYROCARE.NS
Rent Expense Supplemental,2023-03-31 00:00:00,56100000.0,THYROCARE.NS
Diluted Average Shares,2023-03-31 00:00:00,53008823.0,THYROCARE.NS
Basic Average Shares,2023-03-31 00:00:00,52917822.0,THYROCARE.NS
Diluted EPS,2023-03-31 00:00:00,12.14,THYROCARE.NS
Basic EPS,2023-03-31 00:00:00,12.16,THYROCARE.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,644900000.0,THYROCARE.NS
Net Income Common Stockholders,2023-03-31 00:00:00,644900000.0,THYROCARE.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,THYROCARE.NS
Net Income,2023-03-31 00:00:00,644900000.0,THYROCARE.NS
Minority Interests,2023-03-31 00:00:00,1300000.0,THYROCARE.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,643600000.0,THYROCARE.NS
Net Income Continuous Operations,2023-03-31 00:00:00,643600000.0,THYROCARE.NS
Tax Provision,2023-03-31 00:00:00,242300000.0,THYROCARE.NS
Pretax Income,2023-03-31 00:00:00,885900000.0,THYROCARE.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,4400000.0,THYROCARE.NS
Special Income Charges,2023-03-31 00:00:00,4300000.0,THYROCARE.NS
Other Special Charges,2023-03-31 00:00:00,-4300000.0,THYROCARE.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-34500000.0,THYROCARE.NS
Total Other Finance Cost,2023-03-31 00:00:00,24800000.0,THYROCARE.NS
Interest Expense Non Operating,2023-03-31 00:00:00,23500000.0,THYROCARE.NS
Interest Income Non Operating,2023-03-31 00:00:00,13800000.0,THYROCARE.NS
Operating Income,2023-03-31 00:00:00,846200000.0,THYROCARE.NS
Operating Expense,2023-03-31 00:00:00,2788200000.0,THYROCARE.NS
Other Operating Expenses,2023-03-31 00:00:00,848200000.0,THYROCARE.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,387100000.0,THYROCARE.NS
Depreciation Income Statement,2023-03-31 00:00:00,387100000.0,THYROCARE.NS
Selling General And Administration,2023-03-31 00:00:00,435300000.0,THYROCARE.NS
Selling And Marketing Expense,2023-03-31 00:00:00,201800000.0,THYROCARE.NS
General And Administrative Expense,2023-03-31 00:00:00,233500000.0,THYROCARE.NS
Rent And Landing Fees,2023-03-31 00:00:00,56100000.0,THYROCARE.NS
Gross Profit,2023-03-31 00:00:00,3634400000.0,THYROCARE.NS
Cost Of Revenue,2023-03-31 00:00:00,1632300000.0,THYROCARE.NS
Total Revenue,2023-03-31 00:00:00,5266700000.0,THYROCARE.NS
Operating Revenue,2023-03-31 00:00:00,5266700000.0,THYROCARE.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,60567767.43369,THYROCARE.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.226506,THYROCARE.NS
Normalized EBITDA,2022-03-31 00:00:00,2372200000.0,THYROCARE.NS
Total Unusual Items,2022-03-31 00:00:00,267400000.0,THYROCARE.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,267400000.0,THYROCARE.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,1761400000.0,THYROCARE.NS
Reconciled Depreciation,2022-03-31 00:00:00,338700000.0,THYROCARE.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,1696900000.0,THYROCARE.NS
EBITDA,2022-03-31 00:00:00,2639600000.0,THYROCARE.NS
EBIT,2022-03-31 00:00:00,2300900000.0,THYROCARE.NS
Net Interest Income,2022-03-31 00:00:00,-25000000.0,THYROCARE.NS
Interest Expense,2022-03-31 00:00:00,23700000.0,THYROCARE.NS
Interest Income,2022-03-31 00:00:00,7100000.0,THYROCARE.NS
Normalized Income,2022-03-31 00:00:00,1554567767.43369,THYROCARE.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,1761400000.0,THYROCARE.NS
Total Expenses,2022-03-31 00:00:00,3870000000.0,THYROCARE.NS
Rent Expense Supplemental,2022-03-31 00:00:00,30000000.0,THYROCARE.NS
Diluted Average Shares,2022-03-31 00:00:00,52983494.0,THYROCARE.NS
Basic Average Shares,2022-03-31 00:00:00,52888361.0,THYROCARE.NS
Diluted EPS,2022-03-31 00:00:00,33.25,THYROCARE.NS
Basic EPS,2022-03-31 00:00:00,33.3,THYROCARE.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,1761400000.0,THYROCARE.NS
Net Income Common Stockholders,2022-03-31 00:00:00,1761400000.0,THYROCARE.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,THYROCARE.NS
Net Income,2022-03-31 00:00:00,1761400000.0,THYROCARE.NS
Minority Interests,2022-03-31 00:00:00,0.0,THYROCARE.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,1761400000.0,THYROCARE.NS
Net Income Continuous Operations,2022-03-31 00:00:00,1761400000.0,THYROCARE.NS
Tax Provision,2022-03-31 00:00:00,515800000.0,THYROCARE.NS
Pretax Income,2022-03-31 00:00:00,2277200000.0,THYROCARE.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,18000000.0,THYROCARE.NS
Special Income Charges,2022-03-31 00:00:00,215200000.0,THYROCARE.NS
Other Special Charges,2022-03-31 00:00:00,-215200000.0,THYROCARE.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-25000000.0,THYROCARE.NS
Total Other Finance Cost,2022-03-31 00:00:00,8400000.0,THYROCARE.NS
Interest Expense Non Operating,2022-03-31 00:00:00,23700000.0,THYROCARE.NS
Interest Income Non Operating,2022-03-31 00:00:00,7100000.0,THYROCARE.NS
Operating Income,2022-03-31 00:00:00,2018600000.0,THYROCARE.NS
Operating Expense,2022-03-31 00:00:00,2173100000.0,THYROCARE.NS
Other Operating Expenses,2022-03-31 00:00:00,798100000.0,THYROCARE.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,338700000.0,THYROCARE.NS
Depreciation Income Statement,2022-03-31 00:00:00,338700000.0,THYROCARE.NS
Selling General And Administration,2022-03-31 00:00:00,395000000.0,THYROCARE.NS
Selling And Marketing Expense,2022-03-31 00:00:00,221200000.0,THYROCARE.NS
General And Administrative Expense,2022-03-31 00:00:00,173800000.0,THYROCARE.NS
Rent And Landing Fees,2022-03-31 00:00:00,30000000.0,THYROCARE.NS
Gross Profit,2022-03-31 00:00:00,4191700000.0,THYROCARE.NS
Cost Of Revenue,2022-03-31 00:00:00,1696900000.0,THYROCARE.NS
Total Revenue,2022-03-31 00:00:00,5888600000.0,THYROCARE.NS
Operating Revenue,2022-03-31 00:00:00,5888600000.0,THYROCARE.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,THYROCARE.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,THYROCARE.NS
Normalized EBITDA,2021-03-31 00:00:00,,THYROCARE.NS
Total Unusual Items,2021-03-31 00:00:00,,THYROCARE.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,THYROCARE.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,THYROCARE.NS
Reconciled Depreciation,2021-03-31 00:00:00,,THYROCARE.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,THYROCARE.NS
EBITDA,2021-03-31 00:00:00,,THYROCARE.NS
EBIT,2021-03-31 00:00:00,,THYROCARE.NS
Net Interest Income,2021-03-31 00:00:00,,THYROCARE.NS
Interest Expense,2021-03-31 00:00:00,,THYROCARE.NS
Interest Income,2021-03-31 00:00:00,7900000.0,THYROCARE.NS
Normalized Income,2021-03-31 00:00:00,,THYROCARE.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,THYROCARE.NS
Total Expenses,2021-03-31 00:00:00,,THYROCARE.NS
Rent Expense Supplemental,2021-03-31 00:00:00,8400000.0,THYROCARE.NS
Diluted Average Shares,2021-03-31 00:00:00,,THYROCARE.NS
Basic Average Shares,2021-03-31 00:00:00,,THYROCARE.NS
Diluted EPS,2021-03-31 00:00:00,,THYROCARE.NS
Basic EPS,2021-03-31 00:00:00,,THYROCARE.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,THYROCARE.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,THYROCARE.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,THYROCARE.NS
Net Income,2021-03-31 00:00:00,,THYROCARE.NS
Minority Interests,2021-03-31 00:00:00,,THYROCARE.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,THYROCARE.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,THYROCARE.NS
Tax Provision,2021-03-31 00:00:00,,THYROCARE.NS
Pretax Income,2021-03-31 00:00:00,,THYROCARE.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,THYROCARE.NS
Special Income Charges,2021-03-31 00:00:00,,THYROCARE.NS
Other Special Charges,2021-03-31 00:00:00,-58400000.0,THYROCARE.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,THYROCARE.NS
Total Other Finance Cost,2021-03-31 00:00:00,200000.0,THYROCARE.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,THYROCARE.NS
Interest Income Non Operating,2021-03-31 00:00:00,7900000.0,THYROCARE.NS
Operating Income,2021-03-31 00:00:00,,THYROCARE.NS
Operating Expense,2021-03-31 00:00:00,,THYROCARE.NS
Other Operating Expenses,2021-03-31 00:00:00,,THYROCARE.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,THYROCARE.NS
Depreciation Income Statement,2021-03-31 00:00:00,,THYROCARE.NS
Selling General And Administration,2021-03-31 00:00:00,372400000.0,THYROCARE.NS
Selling And Marketing Expense,2021-03-31 00:00:00,238900000.0,THYROCARE.NS
General And Administrative Expense,2021-03-31 00:00:00,133500000.0,THYROCARE.NS
Rent And Landing Fees,2021-03-31 00:00:00,8400000.0,THYROCARE.NS
Gross Profit,2021-03-31 00:00:00,,THYROCARE.NS
Cost Of Revenue,2021-03-31 00:00:00,,THYROCARE.NS
Total Revenue,2021-03-31 00:00:00,,THYROCARE.NS
Operating Revenue,2021-03-31 00:00:00,,THYROCARE.NS
